Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1991 | 06-1991 | 03-1991 | 12-1990 | 09-1990 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -1,296 | N/A | -2,603 | N/A |
| Depreciation Amortization | N/A | 177 | N/A | 123 | N/A |
| Other Working Capital | N/A | 42 | N/A | 639 | N/A |
| Other Operating Activity | 0 | 116 | 0 | 409 | 0 |
| Operating Cash Flow | $N/A | $-961 | $N/A | $-1,433 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -71 | N/A | -109 | N/A |
| Other Investing Activity | 0 | -133 | 0 | 381 | 0 |
| Investing Cash Flow | $N/A | $-204 | $N/A | $272 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 92 | 0 | -79 | 0 |
| Financing Cash Flow | $N/A | $92 | $N/A | $-79 | $N/A |
| Beginning Cash Position | N/A | 1,767 | N/A | 3,007 | N/A |
| End Cash Position | N/A | 694 | N/A | 1,767 | N/A |
| Net Cash Flow | $N/A | $-1,073 | $N/A | $-1,240 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -961 | N/A | -1,433 | N/A |
| Free Cash Flow | 0 | -961 | 0 | -1,433 | 0 |